MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, Y. Z.
Right arrow Articles by Schonbrunn, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, Y. Z.
Right arrow Articles by Schonbrunn, A.

Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins

YZ Gu, PJ Brown, DS Loose-Mitchell, PJ Stork and A Schonbrunn

Department of Pharmacology, University of Texas Medical School, Houston 77225, USA.

The signal transduction pathways regulated by somatostatin receptor subtype 1 (sst1) have been difficult to define because of the variability observed when this receptor is expressed in different cell types by transfection and because pharmacological approaches are inadequate to distinguish sst1 receptor subtypes. To study the sst1 receptor in its endogenous environment, we developed a polyclonal antibody to a 15-amino acid peptide corresponding to a unique sequence in the receptor carboxyl terminus. The peptide antibody routinely precipitated 70% of the soluble [125I-Tyr11]somatostatin/receptor complex prepared from Chinese hamster ovary-K1 cells expressing the sst1 receptor but precipitated < 1% of the complex from cells expressing other sst receptor subtypes. Photoaffinity-labeled sst1 receptor was also specially immunoprecipitated and migrated as a broad 60-kDa band on sodium dodecyl sulfate polyacrylamide gels. The observation that sst receptors from GH4C1 pituitary cells were immunoprecipitated by the antibody and that receptors from AR4-2J pancreatic acinar cells were not indicated that only the former expressed sst1 receptor protein. Because reverse transcription- polymerase chain reaction showed that GH4C1 cells contained both sst1 and sst2 receptor mRNA, immunoprecipitation permitted the sst1 receptor to be separated from the other receptors present. Two observations showed that G proteins were coprecipitated with sst1 receptors from GH4C1 cells. First, pertussis toxin pretreatment markedly decreased hormone binding in the immunoprecipitate. Second, the addition of 20 microM guanosine-5'-(gamma-thio)triphosphate to the immunoprecipitated [125I-Tyr11]somatostatin/receptor complex stimulated the rate of dissociation of bound ligand by 10-fold. Interestingly, however, the dissociation rate of approximately 30% of the ligand/receptor complex was unaffected by guanosine-5'-(gamma-thio)triphosphate. In summary, we have developed an sst1 receptor-specific antibody and used it to show that sst1 receptors endogenously expressed in GH4C1 pituitary cells couple primarily to pertussis toxin-sensitive G proteins. Furthermore, these receptors exist in two distinct high affinity states distinguished by their GTP sensitivity.

Volume 48, Issue 6, pp. 1004-1014, 12/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Sarret, M. J. Esdaile, P. S. McPherson, A. Schonbrunn, H.-J. Kreienkamp, and A. Beaudet
Role of Amphiphysin II in Somatostatin Receptor Trafficking in Neuroendocrine Cells
J. Biol. Chem., February 27, 2004; 279(9): 8029 - 8037.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Hortala, G. Ferjoux, A. Estival, C. Bertrand, S. Schulz, L. Pradayrol, C. Susini, and F. Clemente
Inhibitory Role of the Somatostatin Receptor SST2 on the Intracrine-regulated Cell Proliferation Induced by the 210-Amino Acid Fibroblast Growth Factor-2 Isoform: IMPLICATION OF JAK2
J. Biol. Chem., May 30, 2003; 278(23): 20574 - 20581.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Elberg, R. W. Hipkin, and A. Schonbrunn
Homologous and Heterologous Regulation of Somatostatin Receptor 2
Mol. Endocrinol., November 1, 2002; 16(11): 2502 - 2514.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. R. Albert
G Protein Preferences for Dopamine D2 Inhibition of Prolactin Secretion and DNA Synthesis in GH4 Pituitary Cells
Mol. Endocrinol., August 1, 2002; 16(8): 1903 - 1911.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Ferone, M. P. van Hagen, D. J. Kwekkeboom, P. M. van Koetsveld, D. M. Mooy, E. Lichtenauer-Kaligis, A. Schönbrunn, A. Colao, S. W. J. Lamberts, and L. J. Hofland
Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1719 - 1726.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Sarret, D. Nouel, C. Dal Farra, J.-P. Vincent, A. Beaudet, and J. Mazella
Receptor-mediated Internalization Is Critical for the Inhibition of the Expression of Growth Hormone by Somatostatin in the Pituitary Cell Line AtT-20
J. Biol. Chem., July 2, 1999; 274(27): 19294 - 19300.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L.J. Hofland, Q. Liu, P.M. van Koetsveld, J. Zuijderwijk, F. van der Ham, R.R. de Krijger, A. Schonbrunn, and S.W.J. Lamberts
Immunohistochemical Detection of Somatostatin Receptor Subtypes sst1 and sst2A in Human Somatostatin Receptor Positive Tumors
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 775 - 780.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
T. Florio, H. Yao, K. D. Carey, T. J. Dillon, and P. J. S. Stork
Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1)
Mol. Endocrinol., January 1, 1999; 13(1): 24 - 37.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
P. Dournaud, H. Boudin, A. Schonbrunn, G. S. Tannenbaum, and A. Beaudet
Interrelationships between Somatostatin sst2A Receptors and Somatostatin-Containing Axons in Rat Brain: Evidence for Regulation of Cell Surface Receptors by Endogenous Somatostatin
J. Neurosci., February 1, 1998; 18(3): 1056 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. B. Ain, K. D. Taylor, S. Tofiq, and G. Venkataraman
Somatostatin Receptor Subtype Expression in Human Thyroid and Thyroid Carcinoma Cell Lines
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1857 - 1862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. W. Hipkin, J. Friedman, R. B. Clark, C. M. Eppler, and A. Schonbrunn
Agonist-induced Desensitization, Internalization, and Phosphorylation of the sst2A Somatostatin Receptor
J. Biol. Chem., May 23, 1997; 272(21): 13869 - 13876.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y.-Z. Gu and A. Schonbrunn
Coupling Specificity between Somatostatin Receptor sst2A and G Proteins: Isolation of the Receptor-G Protein Complex with a Receptor Antibody
Mol. Endocrinol., May 1, 1997; 11(5): 527 - 537.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
P. Dournaud, Y. Z. Gu, A. Schonbrunn, J. Mazella, G. S. Tannenbaum, and A. Beaudet
Localization of the Somatostatin Receptor SST2A in Rat Brain Using a Specific Anti-Peptide Antibody
J. Neurosci., July 15, 1996; 16(14): 4468 - 4478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Liu and A. Schonbrunn
Agonist-induced Phosphorylation of Somatostatin Receptor Subtype 1 (Sst1). RELATIONSHIP TO DESENSITIZATION AND INTERNALIZATION
J. Biol. Chem., January 26, 2001; 276(5): 3709 - 3717.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics